1 Table of Contents
1.1 List of Figures
1.2 List of Tables
2 Key Findings, 2018
2.1 Snapshot
2.2 Overview of Refractory Anemia With Excess Blasts Trials

3 Clinical Trials Trends to 2022
3.1 Ongoing Refractory Anemia With Excess Blasts Trials by Phase
3.2 Ongoing Refractory Anemia With Excess Blasts Trials by Type
3.3 Ongoing Refractory Anemia With Excess Blasts Trials by Recruitment Status

4 Country Level Analysis
4.1 Region wise Ongoing Refractory Anemia With Excess Blasts Trials
4.2 Top 10 Countries conducting Refractory Anemia With Excess Blasts Trials
4.3 Trials in Emerging and Developing Economies

5 Company Level Analysis
5.1 Ongoing Refractory Anemia With Excess Blasts Trials by Sponsor Type
5.2 Refractory Anemia With Excess Blasts Subjects by Sponsor Type
5.3 Subjects Recruited by Leading Sponsors

6 Enrolment Trends to 2022
6.1 Subjects Recruited for Refractory Anemia With Excess Blasts Trials by year
6.2 Subjects Recruited for Refractory Anemia With Excess Blasts Trials by Phase
6.3 Subjects Recruited for Refractory Anemia With Excess Blasts Trials by Trial Type
6.4 Subjects Recruited for Refractory Anemia With Excess Blasts Trials by Recruitment Status

7 Ongoing Trials- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company Details
7.1 Ongoing Refractory Anemia With Excess Blasts Trials- Phase 1
7.2 Ongoing Refractory Anemia With Excess Blasts Trials- Phase 2
7.3 Ongoing Refractory Anemia With Excess Blasts Trials- Phase 3
7.4 Ongoing Refractory Anemia With Excess Blasts Trials- Phase 4

8 Appendix
8.1 Abbreviations and Definitions
8.2 Sources and Research Methodology
Figure 1: Refractory Anemia With Excess Blasts- Clinical Trials by Country
Figure 2: Refractory Anemia With Excess Blasts- Clinical Trials by Phase of Development, 2018
Figure 3: Refractory Anemia With Excess Blasts- Clinical Trials by Status, 2018
Figure 4: Refractory Anemia With Excess Blasts- Clinical Trials by Type, 2018
Figure 5: Refractory Anemia With Excess Blasts- Clinical Trials Split by Region, 2000-2018
Figure 6: Refractory Anemia With Excess Blasts- Clinical Trials by Type of Economy, 2018
Figure 7: Refractory Anemia With Excess Blasts- Enrolment by Phase, 2018
Figure 8: Refractory Anemia With Excess Blasts- Enrolment by Trial Type, 2018
Figure 9: Refractory Anemia With Excess Blasts- Enrolment by Recruitment Status, 2018
Figure 10: Refractory Anemia With Excess Blasts- Clinical Trials by Sponsor Type, 2018
Figure 11: Refractory Anemia With Excess Blasts- Enrolment by Type of Sponsors
Figure 12: Refractory Anemia With Excess Blasts- Enrolment by Leading Sponsors
Table 1: Refractory Anemia With Excess Blasts- Clinical Trials by Sponsor Type, 2018
Table 2: Refractory Anemia With Excess Blasts- Clinical Trials by Economy Type, 2018
Table 3: Refractory Anemia With Excess Blasts- Clinical Trials by Region, 2018
Table 4: Refractory Anemia With Excess Blasts- Clinical Trial Participations of Top 10 Countries, 2018
Table 5: Refractory Anemia With Excess Blasts- Clinical Trials in Emerging and Developing Economies, 2018
Table 6: Refractory Anemia With Excess Blasts- Ongoing Phase 1 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 7: Refractory Anemia With Excess Blasts- Ongoing Phase 2 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 8: Refractory Anemia With Excess Blasts- Ongoing Phase 3 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 9: Refractory Anemia With Excess Blasts- Ongoing Phase 4 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company